MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Opposite effects of dopamine on specific NoGo perfomance in young and late onset Parkinson’s disease and the relationship to nigrostriatal degeneration

    D. Kübler, H. Schroll, U. Scheller, R. Buchert, A. Kühn (Berlin, Germany)

    Objective: To investigate inhibitory control under dopamine (DA) in Parkinson’s disease (PD). Background: The pattern of degeneration in PD as well as side effects of…
  • 2018 International Congress

    The Portuguese Version of Montreal Cognitive Assessment as a screening test comparing Vascular Parkinsonism and Parkinson´s Disease in a hospital cross-section study

    A. Velon, M. Mendes, R. Almendra, A. Almeida, M. Correia, C. (Vila Real, Portugal)

    Objective: Compare cognitive function between Vascular Parkinsonism (VaP) and Parkinson´s Disease (PD) patients. Background: Portuguese version of Montreal Cognitive Assessment (MoCA) is a validated screening…
  • 2018 International Congress

    Epidemiological risk factors on cognition with PD patients in male: A cross-sectional study from southwest of China

    Y. Wu, RW. Ou, H. Liu, QQ. Wei, XJ. Gu, Q. Han, LY. Zhang, W. Song, B. Cao, YP. Chen, B. Zhao, HF. Shang (Chengdu, China)

    Objective: To address the effect of the epidemiological risk factors on cognition in male PD patients, taking motor and non-motor clinical features into account. Background:…
  • 2018 International Congress

    Feasibility of a health game on cognition in Parkinson’s disease: Interim analyses of the Parkin’Play Study

    S. vd Weijer, M. Kuijf, A. Duits, R. Kessels, N. de Vries, S. Köhler, G. Tissingh, B. Bloem (Maastricht, Netherlands)

    Objective: The Parkin'Play Study aims to evaluate the feasibility of an individually tailored multi-domain cognitive intervention (a health game) on cognitive performance in Parkinson's Disease…
  • 2018 International Congress

    An investigation of the relationship between computational neuropsychological testing outcomes and symptoms of Parkinson’s disease

    L. Jiang, Y. Zhu, Z. Ye, Z. Pei, L. Chen (Guangzhou, China)

    Objective: The aim of this study was to investigate the relationship between cognition and other symptoms of Parkinson’s disease (PD) using computational neuropsychological tests. Background:…
  • 2018 International Congress

    Diagnostic accuracy and imaging correlates of the Free and Cued Selective Reminding Test for screening mild cognitive impairment in Parkinson’s disease

    J. Pagonabarraga, A. Horta-Barba, J. Marín-Lahoz, S. Martinez-Horta, H. Bejr-Kasem, I. Aracil, J. Pérez-Pérez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

    Objective: To assess the diagnostic accuracy of FCSRT for screening mild cognitive impairment in PD (PD-MCI), and to correlate FCSRT scores with gray and white…
  • 2018 International Congress

    The development of an instrument for measuring Parkinson’s patient empowerment

    P. Viwattanakulvanid (Bangkok, Thailand)

    Objective: To develop a valid and reliable measurement scale of Parkinson’s patient empowerment index (PPEI). Background: Patient empowerment concept has been used as part of…
  • 2018 International Congress

    Effects of computerized cognitive training, with and without concurrent exercise, on executive functions in Parkinson’s disease

    M. Fernandez-del-Olmo, JA. Sánchez-Molina, H. Fernandez-Lago, L. Morenilla-Burlo, J. Gómez-Varela, N. Fogelson (A Coruña, Spain)

    Objective: To explore the effect cognitive training group vs cognitive training with concurrent physical exercise group on executive functions in Parkinson's Disease. Background: PD patients…
  • 2018 International Congress

    Meta-Analysis of Short-afferent inhibition and Cognitive Impairment in Parkinson’s Disease

    J.F. Martin-Rodriguez, P. Mir (Seville, Spain)

    Objective: In this meta-analysis, we assess whether short-afferent inhibition (SAI) is impaired in Parkinson's disease (PD) patients as well as identify clinical variables associated to…
  • 2018 International Congress

    Cognitive Impairment and Depression in Patients with Parkinson’s Disease

    XD. Qu, SS. Li (Lanzhou, China)

    Objective: To evaluate cognitive impairment and depression in patients with Parkinson's Disease (PD) and its relationship. Background: Patients with Parkinson's disease are prone to cognitive…
  • « Previous Page
  • 1
  • …
  • 1524
  • 1525
  • 1526
  • 1527
  • 1528
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley